(2022). Rho-Associated Protein Kinase Inhibitor and Hypoxia Synergistically Enhance the Self-Renewal, Survival Rate, and Proliferation of Human Stem Cells. Stem Cells and Cloning: Advances and Applications.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Rho-Associated Protein Kinase Inhibitor and Hypoxia Synergistically Enhance the Self-Renewal, Survival Rate, and Proliferation of Human Stem Cells."
Stem Cells and Cloning: Advances and Applications 2022.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Rho-Associated Protein Kinase Inhibitor and Hypoxia Synergistically Enhance the Self-Renewal, Survival Rate, and Proliferation of Human Stem Cells."
Stem Cells and Cloning: Advances and Applications, 2022.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.